dopamine injection 200mg/5ml solution for injection, concentrate for
pharmaceutical trading co ltd (0000003066) 33 artemidos avenue, metropolitan court, larnaca, 6025 - dopamine hydrochloride - solution for injection, concentrate for - 200mg/5ml - dopamine hydrochloride (0000062317) 40mg - dopamine
dopamine hydrochloride and dextrose injection solution
hospira, inc. - dopamine hydrochloride (unii: 7l3e358n9l) (dopamine - unii:vtd58h1z2x) - dopamine hydrochloride 160 mg in 100 ml
dopamine- dopamine hydrochloride liquid
deseret biologicals, inc. - dopamine hydrochloride (unii: 7l3e358n9l) (dopamine - unii:vtd58h1z2x) - dopamine hydrochloride 6 [hp_x] in 1 ml - for temporary relief of symptoms including headache, reading difficulty, and poor memory.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms including headache, reading difficulty, and poor memory.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.
dopaminehydrochloride 200 mg/5 ml zb, concentraat voor oplossing voor infusie 200 mg/5 ml
zambon nederland b.v. - dopamine hydrochloride - concentraat voor oplossing voor infusie - kaliummetabisulfiet (e 224) ; stikstof (head space) (e 941) ; water, gezuiverd, - dopamine
dopamine 40mg/ml sterile concentrate
hospira uk limited - dopamine hydrochloride - concentrate for solution for infusion - dopamine hydrochloride 40 mg/ml - cardiac therapy
dopamine hydrochloride and 5% dextrose injection usp solution
hospira healthcare ulc - dopamine hydrochloride; dextrose - solution - 1.6mg; 50mg - dopamine hydrochloride 1.6mg; dextrose 50mg - selective beta 1-adrenergic agonists
dopamine hydrochloride and 5% dextrose injection usp solution
hospira healthcare ulc - dopamine hydrochloride; dextrose - solution - 0.8mg; 50mg - dopamine hydrochloride 0.8mg; dextrose 50mg - selective beta 1-adrenergic agonists
dopamine hydrochloride and 5% dextrose injection usp solution
hospira healthcare ulc - dopamine hydrochloride; dextrose - solution - 3.2mg; 50mg - dopamine hydrochloride 3.2mg; dextrose 50mg - selective beta 1-adrenergic agonists
myocard-dx- dopamine hydrochloride in dextrose injection
b. braun medical inc. - dopamine hydrochloride (unii: 7l3e358n9l) (dopamine - unii:vtd58h1z2x), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dopamine hydrochloride 80 mg in 100 ml - dopamine hydrochloride in 5% dextrose injection usp is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarctions, trauma, endotoxic septicemia, open heart surgery, renal failure, and chronic cardiac decompensation as in congestive heart failure. where appropriate, restoration of blood volume with a suitable plasma expander or whole blood should be instituted or completed prior to administration of dopamine. patients most likely to respond adequately to administration of dopamine are those in whom physiological parameters such as urine flow, myocardial function, and blood pressure, have not undergone profound deterioration. multiclinic trials indicate that the shorter the time interval between onset of signs and symptoms and initiation of therapy with volume correction and dopamine, the better the prognosis. poor perfusion of vital organs - urine flow appears to be one of the diagnostic signs by which adequacy of vital organ perfusion can be monitored.
dopamine hci - fresenius 200 mg5 ml
medic trim healthcare ltd - dopamine hydrochloride - solution for infusion - dopamine hydrochloride 200 mg / 5 ml - dopamine - to correct hemodynamic imbalances associated with myocardial infarction trauma septic shock and cardiac surgery. dopamine hydrochloride is used in the treatment of : 1. shock unresponsive to replacement of fluid loss and especially where renal function is impaired. 2. to correct haemodynamic imbalances associated with myocardial infarction trauma septic shock and cardiac surgery. 3. it is also used in the management of chtonic refractory congestive heart failure.